Deb Wasser, IRC Executive Vice President, US Practice Lead , Edelman Financial Communications Deb Wasser advises the senior management and boards of public companies on strategic communications including investor relations, financial and corporate public relations, transaction communications, crisis communications and leadership positioning. Deb leads Edelman’s Investor Relations practice in NY, and helps to advise clients globally on IR issues. Current clients include companies in media, consumer products, retail, healthcare, broad industrial sectors and technology. Prior to joining Edelman in 2015, Deb was Senior Vice President, Investor Relations & Corporate Communications for Veeco Instruments (Nasdaq: VECO; multi-billion dollar market cap technology company) for over 15 years. Deb was the recipient of the IR Magazine Award for “Best IRO,” Small Cap Company; was top-Ranked sector “Institutional Investor” IRO, and was appointed to the NIRI Senior Roundtable. Deb is Board Member of NIRI New York and active in conference organization at the national level. While at Veeco, Deb created and implemented a global IR program to raise visibility and deepen ownership to reflect business trends: annual program included more than 25 IR conferences and NDRs including Europe and Asia outreach. Veeco’s analyst coverage grew from 5 to over 25. She led effective communications strategy through positive periods of growth, over a dozen M&A transactions, a highly successful secondary equity offering, new market opportunities, one CEO and two CFO transitions, an accounting review, as well as business declines and restructurings. Prior to joining Veeco, Deb was Vice President of Dewe Rogerson Inc. in NY where she ran the firm’s U.S. IR client base, focused on healthcare/ biotech, high-tech, consumer products (food, apparel), financial services, publishing and general industry. During her tenure at the firm, Deb serviced clients across the globe and helped grow the firm from 4 to 80 employees. Deb also served for one year as Director of Investor Relations for Immunomedics, a biotechnology company. Deb has a BS in Communications and Business from The State University of New York at Albany.